Eileen M. Denovan‐Wright

5.1k total citations · 2 hit papers
96 papers, 4.1k citations indexed

About

Eileen M. Denovan‐Wright is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Eileen M. Denovan‐Wright has authored 96 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 46 papers in Cellular and Molecular Neuroscience and 29 papers in Pharmacology. Recurrent topics in Eileen M. Denovan‐Wright's work include Cannabis and Cannabinoid Research (28 papers), Neuroscience and Neuropharmacology Research (25 papers) and Genetic Neurodegenerative Diseases (22 papers). Eileen M. Denovan‐Wright is often cited by papers focused on Cannabis and Cannabinoid Research (28 papers), Neuroscience and Neuropharmacology Research (25 papers) and Genetic Neurodegenerative Diseases (22 papers). Eileen M. Denovan‐Wright collaborates with scholars based in Canada, United States and Saudi Arabia. Eileen M. Denovan‐Wright's co-authors include Robert B. Laprairie, Michael E. Kelly, Amina M. Bagher, H.A. Robertson, Jonathan Wright, Andrea L.O. Hebb, Rong‐Zong Liu, Bernard Thisse, Ronald J. Mandel and Christine Thisse and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Eileen M. Denovan‐Wright

96 papers receiving 4.0k citations

Hit Papers

Cannabidiol is a negative allosteric modulator of the can... 2015 2026 2018 2022 2015 2018 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cannabidiol is a negative allosteric modulator of the cannabinoid CB 1 receptor
    2015 790 citations Robert B. Laprairie, Amina M. Bagher et al. British Journal of Pharmacology profile →
  2. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol‐dimethylheptyl at the type 1 and type 2 cannabinoid receptors
    2018 253 citations Mylyne Tham, Orhan Yılmaz et al. British Journal of Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eileen M. Denovan‐Wright Canada 35 1.9k 1.9k 1.7k 351 341 96 4.1k
Anne Zimmer United States 21 2.3k 1.2× 1.4k 0.8× 2.0k 1.2× 149 0.4× 602 1.8× 25 4.3k
Martin Häring Germany 22 751 0.4× 1.4k 0.8× 1.2k 0.7× 250 0.7× 383 1.1× 30 3.7k
José Miguel Vela Spain 38 887 0.5× 2.4k 1.3× 2.0k 1.2× 391 1.1× 213 0.6× 133 4.8k
Rosa M. Tolón Spain 28 2.4k 1.3× 605 0.3× 1.7k 1.0× 89 0.3× 545 1.6× 52 3.3k
Emmanuel Hermans Belgium 34 721 0.4× 2.0k 1.1× 2.5k 1.5× 131 0.4× 257 0.8× 149 4.3k
Alice C. Young United States 11 3.8k 2.0× 2.5k 1.3× 3.4k 2.0× 186 0.5× 852 2.5× 11 6.4k
Muna Abu-Shaar United States 7 3.8k 2.0× 1.5k 0.8× 2.2k 1.3× 195 0.6× 774 2.3× 7 5.2k
Michael McKinney United States 39 907 0.5× 2.1k 1.1× 2.3k 1.4× 166 0.5× 1.1k 3.4× 92 5.0k
Jing Du United States 38 1.1k 0.6× 2.4k 1.3× 2.9k 1.7× 103 0.3× 583 1.7× 88 6.2k
Luigia Cristino Italy 39 2.8k 1.5× 872 0.5× 1.6k 1.0× 150 0.4× 930 2.7× 89 5.0k

Countries citing papers authored by Eileen M. Denovan‐Wright

Since Specialization
Citations

This map shows the geographic impact of Eileen M. Denovan‐Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eileen M. Denovan‐Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eileen M. Denovan‐Wright more than expected).

Fields of papers citing papers by Eileen M. Denovan‐Wright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eileen M. Denovan‐Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eileen M. Denovan‐Wright. The network helps show where Eileen M. Denovan‐Wright may publish in the future.

Co-authorship network of co-authors of Eileen M. Denovan‐Wright

This figure shows the co-authorship network connecting the top 25 collaborators of Eileen M. Denovan‐Wright. A scholar is included among the top collaborators of Eileen M. Denovan‐Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eileen M. Denovan‐Wright. Eileen M. Denovan‐Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Young, A. P., Anna-Maria Szczesniak, Karolynn Hsu, Michael E. Kelly, & Eileen M. Denovan‐Wright. (2024). Enantiomeric Agonists of the Type 2 Cannabinoid Receptor Reduce Retinal Damage during Proliferative Vitreoretinopathy and Inhibit Hyperactive Microglia In Vitro. ACS Pharmacology & Translational Science. 7(5). 1348–1363. 5 indexed citations
2.
Young, A. P., et al.. (2021). Endothelin B receptor dysfunction mediates elevated myogenic tone in cerebral arteries from aged male Fischer 344 rats. GeroScience. 43(3). 1447–1463. 10 indexed citations
3.
Laprairie, Robert B., Amina M. Bagher, Jillian L. Rourke, et al.. (2019). Positive allosteric modulation of the type 1 cannabinoid receptor reduces the signs and symptoms of Huntington's disease in the R6/2 mouse model. Neuropharmacology. 151. 1–12. 44 indexed citations
4.
Manchia, Mirko, Stefano Comai, Martina Pinna, et al.. (2019). Biomarkers in aggression. Advances in clinical chemistry. 93. 169–237. 17 indexed citations
5.
Tham, Mylyne, Orhan Yılmaz, Mariam Alaverdashvili, et al.. (2018). Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol‐dimethylheptyl at the type 1 and type 2 cannabinoid receptors. British Journal of Pharmacology. 176(10). 1455–1469. 253 indexed citations breakdown →
6.
Laprairie, Robert B., Amina M. Bagher, & Eileen M. Denovan‐Wright. (2016). Cannabinoid receptor ligand bias: implications in the central nervous system. Current Opinion in Pharmacology. 32. 32–43. 55 indexed citations
7.
Laprairie, Robert B., Amina M. Bagher, Michael E. Kelly, & Eileen M. Denovan‐Wright. (2015). Cannabidiol is a negative allosteric modulator of the cannabinoid CB 1 receptor. British Journal of Pharmacology. 172(20). 4790–4805. 790 indexed citations breakdown →
8.
Straiker, Alex, Susan E. Howlett, Amina M. Bagher, et al.. (2014). Cannabinoid and lipid-mediated vasorelaxation in retinal microvasculature. European Journal of Pharmacology. 735. 105–114. 52 indexed citations
9.
10.
Laprairie, Robert B., Michael E. Kelly, & Eileen M. Denovan‐Wright. (2013). Cannabinoids increase type 1 cannabinoid receptor expression in a cell culture model of striatal neurons: Implications for Huntington's disease. Neuropharmacology. 72. 47–57. 35 indexed citations
11.
Pyle, W. Glen, et al.. (2013). The Impact of Ovariectomy on Calcium Homeostasis and Myofilament Calcium Sensitivity in the Aging Mouse Heart. PLoS ONE. 8(9). e74719–e74719. 32 indexed citations
12.
Karanth, Santhosh, Eileen M. Denovan‐Wright, Christine Thisse, Bernard Thisse, & Jonathan Wright. (2008). The evolutionary relationship between the duplicated copies of the zebrafish fabp11 gene and the tetrapod FABP4, FABP5, FABP8 and FABP9 genes. FEBS Journal. 275(12). 3031–3040. 38 indexed citations
13.
Denovan‐Wright, Eileen M., et al.. (2008). Sustained striatal ciliary neurotrophic factor expression negatively affects behavior and gene expression in normal and R6/1 mice. Journal of Neuroscience Research. 86(8). 1748–1757. 11 indexed citations
14.
Sharma, Mukesh Kumar, Rong‐Zong Liu, Christine Thisse, et al.. (2006). Hierarchical subfunctionalization of fabp1a, fabp1b and fabp10 tissue‐specific expression may account for retention of these duplicated genes in the zebrafish (Danio rerio) genome. FEBS Journal. 273(14). 3216–3229. 51 indexed citations
15.
Liu, Rong‐Zong, Qian Sun, Christine Thisse, et al.. (2004). The Cellular Retinol-Binding Protein Genes Are Duplicated and Differentially Transcribed in the Developing and Adult Zebrafish (Danio rerio). Molecular Biology and Evolution. 22(3). 469–477. 28 indexed citations
16.
Hebb, Andrea L.O., H.A. Robertson, & Eileen M. Denovan‐Wright. (2004). Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington′s disease transgenic mice prior to the onset of motor symptoms. Neuroscience. 123(4). 967–981. 131 indexed citations
17.
Liu, Rong‐Zong, Eileen M. Denovan‐Wright, Agnès Degrave, et al.. (2004). Differential expression of duplicated genes for brain-type fatty acid-binding proteins (fabp7a and fabp7b) during early development of the CNS in zebrafish (Danio rerio). Gene Expression Patterns. 4(4). 379–387. 40 indexed citations
18.
19.
Denovan‐Wright, Eileen M., Gregory R. Ferrier, H.A. Robertson, & Susan E. Howlett. (2000). Increased Expression of the Gene for α-Interferon-Inducible Protein in Cardiomyopathic Hamster Heart. Biochemical and Biophysical Research Communications. 267(1). 103–108. 6 indexed citations
20.
Denovan‐Wright, Eileen M. & Robert W. Lee. (1994). Comparative Structure and Genomic Organization of the Discontinuous Mitochondrial Ribosomal RNA Genes of Chlamydomonas eugametos and Chlamydomonas reinhardtii. Journal of Molecular Biology. 241(2). 298–311. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Zimmer Breakdown of academic impact, for papers by Martin Häring Breakdown of academic impact, for papers by José Miguel Vela Breakdown of academic impact, for papers by Rosa M. Tolón Breakdown of academic impact, for papers by Emmanuel Hermans Breakdown of academic impact, for papers by Alice C. Young Breakdown of academic impact, for papers by Muna Abu-Shaar Breakdown of academic impact, for papers by Michael McKinney Breakdown of academic impact, for papers by Jing Du Breakdown of academic impact, for papers by Luigia Cristino
Rankless by CCL
2026